In vitro selection of resistant Helicobacter pylori
Open Access
- 1 September 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (9), 1637-1641
- https://doi.org/10.1128/aac.34.9.1637
Abstract
Four strains of Helicobacter pylori were subjected to an in vitro serial passage technique to compare the propensity of the organisms to develop resistance to seven classes of antibacterial agents. The passages were made on serially doubling concentrations of antibacterial agents incorporated into agar starting at one-half the base-line MIC. The frequency of spontaneous resistance was also determined for each strain at four and eight times the MIC of each antibacterial agent. Strains resistant to ciprofloxacin, metronidazole, erythromycin, and tobramycin were isolated. The experiments failed to select organisms resistant to bismuth subsalicylate, furazolidone, or amoxicillin, although the MIC of amoxicillin was increased 4- to 16-fold. With the exception of erythromycin, organisms with the selected resistance were stable after at least three passages on antibacterial agent-free medium. Spontaneous resistance rates were generally of a low magnitude and were not predictive of the serial passage results.This publication has 21 references indexed in Scilit:
- PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORIThe Lancet, 1988
- Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosaJournal of Antimicrobial Chemotherapy, 1988
- Susceptibility of Campylobacter pylori to macrolides and fluoroquinolonesJournal of Antimicrobial Chemotherapy, 1988
- Susceptibility of clinical isolates ofCampylobacter pylori to twenty-one antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.Journal of Clinical Pathology, 1988
- CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDYThe Lancet, 1987
- Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.BMJ, 1986
- Susceptibility of Campylobacter pyloridis to 20 antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agarAntimicrobial Agents and Chemotherapy, 1983
- Chemotherapeutic properties of prominent nitrofuransJournal of Antimicrobial Chemotherapy, 1976